首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

基因分型市場規模、佔有率和成長分析（按產品、技術、應用、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902019

基因分型市場規模、佔有率和成長分析（按產品、技術、應用、最終用途和地區分類）－2026-2033年產業預測

Genotyping Market Size, Share, and Growth Analysis, By Product (Instruments, Reagents & Kits), By Technology (PCR, Capillary Electrophoresis), By Application, By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，基因分型市場規模將達到 182.9 億美元，到 2025 年將達到 205.2 億美元，到 2033 年將達到 515.4 億美元，在預測期（2026-2033 年）內，複合年成長率為 12.2%。

全球基因分型市場正經歷顯著擴張，這主要得益於基因組學領域的創新、個人化醫療的進步以及對基因檢測需求的不斷成長。這一成長主要由遺傳疾病發病率的上升、意識提升以及精準醫療的進步所驅動。微陣列、聚合酵素鏈鎖反應(PCR) 和次世代定序(NGS) 等多種基因分型技術已廣泛應用於研究和臨床領域。此外，基因分型數據與生物資訊學和數據分析的協同作用也推動了市場的成長趨勢。在競爭激烈的市場環境中，主要企業正優先考慮產品創新、拓展基因檢測服務並建立策略聯盟，以鞏固其市場地位。

基因分型市場促進因素

基因分型市場的主要促進因素是遺傳疾病發生率的上升和人們對個人化醫療日益成長的興趣。基因分型對於檢測與特定疾病和治療反應相關的基因變異、突變和基因序列至關重要。隨著基因組學研究的進步和對遺傳標記的深入了解，基因分型能夠實現個人化診斷、治療策略和藥物選擇。遺傳疾病的日益增加以及精準醫療的興起，正在推動對基因分型技術和服務的需求。這一趨勢凸顯了基因分型在現代醫學中的關鍵作用。

基因分型市場限制因素

全球基因分型市場面臨主要與基因檢測相關的倫理和隱私挑戰。個人基因數據的可近性引發了人們對濫用和誤讀可能性的嚴重擔憂。知情同意、資料安全以及基於基因資訊的歧視風險等問題阻礙了基因分型技術的廣泛接受和應用。此外，基因檢測結果的適當溝通和解讀也需要格外重視，以確保結果清晰明了，並指導個人和醫療保健提供者做出適當的回應。解決這些倫理和隱私挑戰對於建立信任、促進公眾參與以及確保基因分型技術的負責任實施至關重要。

基因分型市場趨勢

基因分型市場正經歷著向個人化和精準醫療的重大轉變，從根本上改變了患者的治療方法。隨著我們對基因變異與疾病進展和藥物療效之間關聯的理解不斷加深，對基因分型技術的需求也隨之成長。基因組技術的進步及其帶來的成本降低，使得醫療專業人員和研究人員能夠更便捷地獲得相關技術。這一發展趨勢促進了針對每位患者基因譜量身定做的個人化治療方案的製定，從而提高了治療效果和疾病管理水平。因此，基因分型已成為現代醫學的基石，有助於進行標靶干預並最佳化患者預後。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.（United States）
Illumina, Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
F. Hoffmann-La Roche Ltd（Switzerland）
Danaher Corporation（United States）
PerkinElmer, Inc.（United States）
Fluidigm Corporation（United States）
Eurofins Scientific（Luxembourg）
Pacific Biosciences of California, Inc.（United States）
Oxford Nanopore Technologies Ltd.（United Kingdom）
Takara Bio Inc.（Japan）

結論與建議

簡介目錄

Product Code: SQMIG35D2088

Genotyping Market size was valued at USD 18.29 Billion in 2024 and is poised to grow from USD 20.52 Billion in 2025 to USD 51.54 Billion by 2033, growing at a CAGR of 12.2% during the forecast period (2026-2033).

The global genotyping market is witnessing significant expansion, propelled by innovations in genomics, personalized medicine, and a heightened demand for genetic testing. This growth is largely driven by an increasing incidence of genetic disorders, greater public awareness regarding early disease detection, and advances in precision medicine. Various genotyping technologies, such as microarrays, polymerase chain reaction (PCR), and next-generation sequencing (NGS), are extensively utilized across both research and clinical applications. Furthermore, the synergy between genotyping data and bioinformatics, along with data analytics, is contributing to the market's upward trajectory. The competitive landscape features major players prioritizing product innovation, enlarging their genetic testing offerings, and forging strategic partnerships to enhance their market presence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genotyping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genotyping Market Segments Analysis

Global Genotyping Market is segmented by Product, Technology, Application, End-use and region. Based on Product, the market is segmented into Instruments, Reagents & Kits and Software and Services. Based on Technology, the market is segmented into PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry and Others. Based on Application, the market is segmented into Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics and Others. Based on End-use, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genotyping Market

A significant factor propelling the genotyping market is the heightened occurrence of genetic disorders alongside an increasing interest in personalized medicine. Genotyping is essential for detecting genetic variations, mutations, and gene sequences that correlate with particular illnesses or responses to treatments. As genomic research advances and our comprehension of genetic markers deepens, genotyping facilitates tailored diagnosis, treatment strategies, and drug selection. The combination of a growing incidence of genetic disorders and the movement towards precision medicine drives the rising demand for genotyping technologies and services. This trend underscores the critical role of genotyping in modern healthcare.

Restraints in the Genotyping Market

The global genotyping market faces notable challenges primarily stemming from ethical and privacy issues linked to genetic testing. The ability to access personal genetic data raises significant concerns regarding potential misuse or misinterpretation. Issues surrounding informed consent, data security, and the risk of discrimination based on genetic information hinder broader acceptance and application of genotyping. Additionally, the proper communication and interpretation of genetic test results demand meticulous attention to ensure clarity and guide appropriate responses from individuals and healthcare providers. Tackling these ethical and privacy dilemmas is essential to foster trust, enhance participation, and ensure the responsible implementation of genotyping technologies.

Market Trends of the Genotyping Market

The Genotyping market is witnessing a significant shift toward personalized medicine and precision healthcare, fundamentally transforming patient treatment approaches. As the understanding of genetic variations and their link to disease progression and drug efficacy deepens, the demand for genotyping technologies rises correspondingly. The advances in genomic technologies and their consequent reduction in costs are democratizing access for healthcare professionals and researchers alike. This evolution facilitates the development of individualized treatment regimens tailored to each patient's genetic profile, enhancing therapeutic efficacy and disease management. As a result, genotyping is emerging as a cornerstone of modern healthcare, fostering targeted interventions and optimizing patient outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Analysis

Global Genotyping Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Reagents & Kits
Software and Services

Global Genotyping Market Size by Technology & CAGR (2026-2033)

Market Overview
PCR
Capillary Electrophoresis
Microarrays
Sequencing
Mass Spectrometry
Others

Global Genotyping Market Size by Application & CAGR (2026-2033)

Market Overview
Pharmacogenomics
Diagnostics and Personalized Medicine
Agricultural Biotechnology
Animal Genetics
Others

Global Genotyping Market Size by End-use & CAGR (2026-2033)

Market Overview
Pharmaceutical and Biopharmaceutical Companies
Diagnostics and Research Laboratories
Academic Institutes
Others

Global Genotyping Market Size & CAGR (2026-2033)

North America (Product, Technology, Application, End-use)
- US
- Canada
Europe (Product, Technology, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments